
Overview
With his many speaking engagements and commitment to education, Dr. Neil Morganstein has a reputation as a leader in the treatment of hematological and oncological issues. He is a national speaker in the area of multiple myeloma, as well as co-chair of a video conference on the management of patients with multiple myeloma. He has a special interest in lung cancer and multiple myeloma, and has published and presented several peer-reviewed articles, posters and abstracts at regional and national oncology meetings. These have focused on multiple myeloma, lymphoma, prostate cancer, gastric cancer, and hematological complications during pregnancy.As an involved and committed oncologist at Overlook Medical Center’s Carol G. Simon Cancer Center, Dr. Morganstein gives several lectures a year educating medical students. He teaches the hematology board review course for the American College of Physicians, as well as the hematology and oncology course for residents at Rutgers University. In addition, he thoroughly enjoys working with medical students in the hospital.Dr. Morganstein completed his hematology and oncology fellowship at Robert Wood Johnson University Hospital of New Brunswick, New Jersey, where he also finished his residency training, while serving as chief resident. He is board-certified in medical oncology, hematology and internal medicine and maintains membership in many distinguished organizations, including the American Society of Clinical Oncologists and the American Society of Hematologists.
Dr. Morganstein is rated as an Experienced provider by MediFind in the treatment of Familial Wilms Tumor 2. His top areas of expertise are Large-Cell Immunoblastic Lymphoma, Classical Hodgkin Lymphoma, Hodgkin Lymphoma, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Bone Marrow Aspiration.
His clinical research consists of co-authoring 5 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
99 Beauvoir Avenue, Summit, NJ 07901
1000 Galloping Hill Road, Suite 204, Union, NJ 07083
Additional Areas of Focus
Dr. Morganstein has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Northwell Health Physician Partners Smith Institute For Urology At Lake Success
Louis Kavoussi is an Oncologist in Lake Success, New York. Dr. Kavoussi is rated as an Elite provider by MediFind in the treatment of Familial Wilms Tumor 2. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Nephrectomy, and Reconstructive Urology Surgery.
Memorial Solid Tumor Group
Robert Motzer is an Oncologist in New York, New York. Dr. Motzer is rated as an Elite provider by MediFind in the treatment of Familial Wilms Tumor 2. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Teratoma of the Mediastinum, Nephrectomy, and Orchiectomy.
Weill Medical College Of Cornell
Rohit Jain is an Oncologist and a Hematologist Oncology provider in New York, New York. Dr. Jain is rated as a Distinguished provider by MediFind in the treatment of Familial Wilms Tumor 2. His top areas of expertise are WT1-Related Wilms Tumor Syndromes, Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, and Familial Wilms Tumor 2. Dr. Jain is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Classical Hodgkin LymphomaDr. Morganstein isDistinguished. Learn about Classical Hodgkin Lymphoma.
- Hodgkin LymphomaDr. Morganstein isDistinguished. Learn about Hodgkin Lymphoma.
- Large-Cell Immunoblastic LymphomaDr. Morganstein isDistinguished. Learn about Large-Cell Immunoblastic Lymphoma.
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Schnitzler SyndromeDr. Morganstein isDistinguished. Learn about Schnitzler Syndrome.
- ThrombocytopeniaDr. Morganstein isDistinguished. Learn about Thrombocytopenia.
- Advanced
- Angioimmunoblastic T-cell LymphomaDr. Morganstein isAdvanced. Learn about Angioimmunoblastic T-cell Lymphoma.
- Burkitt LymphomaDr. Morganstein isAdvanced. Learn about Burkitt Lymphoma.
- Chronic B-Cell Leukemia (CBCL)Dr. Morganstein isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Dr. Morganstein isAdvanced. Learn about Chronic Lymphocytic Leukemia (CLL).
- Diffuse Large B-Cell Lymphoma (DLBCL)Dr. Morganstein isAdvanced. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- Gastric LymphomaDr. Morganstein isAdvanced. Learn about Gastric Lymphoma.
- Experienced
- Acute Eosinophilic PneumoniaDr. Morganstein isExperienced. Learn about Acute Eosinophilic Pneumonia.
- Acute Myeloblastic Leukemia with MaturationDr. Morganstein isExperienced. Learn about Acute Myeloblastic Leukemia with Maturation.
- Acute Myeloblastic Leukemia without MaturationDr. Morganstein isExperienced. Learn about Acute Myeloblastic Leukemia without Maturation.
- Acute Myeloid Leukemia (AML)Dr. Morganstein isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adult Immune ThrombocytopeniaDr. Morganstein isExperienced. Learn about Adult Immune Thrombocytopenia.
- ALK-Positive Non-Small Cell Lung CancerDr. Morganstein isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.

